OpenArc Corporate Advisory »

Arcutis Biotherapeutics shares owned by OpenArc Corporate Advisory

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by OpenArc Corporate Advisory from 13F filings

Historical chart of OpenArc Corporate Advisory investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by OpenArc Corporate Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by OpenArc Corporate Advisory

Quarter filed Position value Share count Share price at filing
2026-03-31 $721k 31k 23.56

More positions owned by OpenArc Corporate Advisory

NVIDIA Corporation (NVDA)
Ishares Tr Rus 1000 Grw Etf (IWF)
Blackrock Etf Trust Ishares A I Inno (BAI)
Tcw Transform Etf Trust Transform System (PWRD)
J P Morgan Exchange Traded F Core Plus Bd Etf (JCPB)
Ishares Tr Core Msci Eafe (IEFA)
Ab Active Etfs Emerging Mkts Op (EMOP)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Home Depot (HD)
Spdr Gold Tr Gold Shs (GLD)
Vanguard Scottsdale Fds Vng Rus1000val (VONV)
J P Morgan Exchange Traded F Active Value Etf (JAVA)
Ishares Tr Rus 1000 Val Etf (IWD)
Blackrock Etf Trust Ii Ishares Flexible (BINC)
Apple (AAPL)

View all positions for OpenArc Corporate Advisory

Top funds holding Arcutis Biotherapeutics

Suvretta Capital Management
Frazier Life Sciences Management
BlackRock
Rubric Capital Management
Vanguard Group
Polar Capital Holdings
State Street Corporation
Jennison Associates
Vanguard Capital Management
Gilder, Gagnon, Howe & Co
Morgan Stanley
UBS Group
Geode Capital Management
Driehaus Capital Management
D. E. Shaw & Co

View all funds holding Arcutis Biotherapeutics